Ownership history in BRAIDWELL LP · 13 quarters on record
This page tracks every 13F SEC filing in which BRAIDWELL LP reported a position in XENON PHARMACEUTICALS INC (XENE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 1,825,076 | -1,779,953 | -49.4% | 2.62% | $81.8M | $44.82 |
| 2025 Q3 | UNCHANGED | 3,605,029 | — | 0% | 4.29% | $144.7M | $40.15 |
| 2025 Q2 | ADDED | 3,605,029 | +895,154 | +33.0% | 3.86% | $112.8M | $31.30 |
| 2025 Q1 | REDUCED | 2,709,875 | -204,089 | -7.0% | 3.20% | $90.9M | $33.55 |
As of 2025 Q4 — sorted by position size